Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma

Journal of the American Veterinary Medical Association

Volumn 211, Issue 1, 1997, Pages 79-81

  Eiler, Hugo ^a,b   Oliver, Jack W ^a   Andrews, Frank M ^a   Fecteau, Kellie A ^a   Green, Eleanor M ^a   McCracken, Malcolm ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; PROTIRELIN;

ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; HORSE DISEASE; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADENOMA; HYPOPHYSIS INTERMEDIATE LOBE; HYPOPHYSIS TUMOR; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PROVOCATION TEST;

ADENOMA; ANIMALS; CASE-CONTROL STUDIES; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HORSE DISEASES; HORSES; HYDROCORTISONE; PITUITARY GLAND; PITUITARY NEOPLASMS; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN-RELEASING HORMONE;

ANIMALIA; EQUIDAE; EQUUS CABALLUS; PIPA;

EID: 0030762435     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Beech J, Garcia M. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma. Am J Vet Res 1985;46:1941-1943.
2. Eiler H, Oliver J, Goble D. Combined dexamethasone suppression cosyntropin-(synthetic ACTH-)stimulation test in the horse: a new approach to testing of adrenal gland function. Am J Vet Res 1980;41:430-434.
3. van der Kolk JH, Kalsbeek HC, van Garderen E, et al. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992). Vet Rec 1993;133:594-597.
4. Wilson MG, Nicholson WE, Holscher MA, et al. Proopiomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. Endocrinology 1982;110:941-954.
5. Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology 1982;110:1430-1441.
6. Millington WR, Dybdal NO, Dawson R Jr, et al. Equine Cushing's disease: differential regulation of β-endorphin processing in tumors of the intermediate pituitary. Endocrinology 1988;123:1598-1604.
7. Couetil L, Paradis MR, Knoll J. Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J Vet Intern Med 1996;10:1-6.
8. van der Kolk JH, Wensing T, Kalsbeek HC, et al. Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest Anim Endocrinol 1995;12:35-39.
9. Feldman EC, Nelson RW. Hyperadrenocorticism. In: Feldman EC, Nelson RW, eds. Canine and feline endocrinology and reproduction. 2nd ed. Philadelphia: WB Saunders Co, 1996;187-255.
10. Dybdal NO, Hargraves KM, Madigan JE, et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 1994;204:627-632.
11. Pieters GF, Smals AG, Benraad JT, et al. Plasma cortisol response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone in Cushing's disease. J Clin Endocrinol Metab 1979;48:874-876.
12. Neiman LK, Chrousos GP, Oldfield EH, et al. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med 1986;105:862-867.
13. Holsboer-Trachler E, Stohler F, Hatzinger M. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res 1991;38:163-171.